Tartrazine


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000077260 Sleepiness PMID:39619924
MESH:D000740 Anemia PMID:22317828; PMID:30096597
MESH:D000799 Angioedema PMID:14656361; PMID:3894321
MESH:D001008 Anxiety Disorders PMID:31936188
MESH:D001068 Feeding and Eating Disorders PMID:39619924
MESH:D001249 Asthma PMID:3894321
MESH:D001289 Attention Deficit Disorder with Hyperactivity PMID:7965420
MESH:D001791 Blood Platelet Disorders PMID:29981020
MESH:D001835 Body Weight PMID:16087284
MESH:D001847 Bone Diseases PMID:39619970
MESH:D001930 Brain Injuries PMID:31936188
MESH:D001943 Breast Neoplasms PMID:34972512
MESH:D002869 Chromosome Aberrations PMID:2209081
MESH:D003875 Drug Eruptions PMID:9431719
MESH:D004342 Drug Hypersensitivity PMID:10937604; PMID:9018987
MESH:D004489 Edema, Cardiac PMID:31933405
MESH:D005355 Fibrosis PMID:30847814
MESH:D006229 Hand Dermatoses PMID:9431719
MESH:D006402 Hematologic Diseases PMID:30096597; PMID:31936188
MESH:D006461 Hemolysis PMID:29981020
MESH:D006470 Hemorrhage PMID:30096597; PMID:39619970
MESH:D006948 Hyperkinesis PMID:3894321
MESH:D006967 Hypersensitivity PMID:150265
MESH:D007674 Kidney Diseases PMID:22317828; PMID:29981020; PMID:32981412; PMID:39619970
MESH:D007683 Kidney Tubular Necrosis, Acute PMID:30847814
MESH:D007964 Leukocytosis PMID:30096597
MESH:D008103 Liver Cirrhosis PMID:29981020
MESH:D009410 Nerve Degeneration PMID:31936188
MESH:D011297 Prenatal Exposure Delayed Effects PMID:18687399; PMID:39619970
MESH:D011694 Purpura, Hyperglobulinemic PMID:10068932
MESH:D011695 IgA Vasculitis PMID:8214803
MESH:D012220 Rhinitis PMID:14763933
MESH:D013122 Spinal Diseases PMID:31933405
MESH:D013158 Splenic Diseases PMID:30096597
MESH:D013163 Splenomegaly PMID:30096597
MESH:D013610 Tachycardia PMID:39619924
MESH:D013733 Testicular Diseases PMID:33565293
MESH:D014581 Urticaria PMID:14656361; PMID:9053127
MESH:D015431 Weight Loss PMID:22317828; PMID:28239801; PMID:29854586; PMID:864790
MESH:D015775 Fractures, Stress PMID:39619970
MESH:D018366 Vasculitis, Leukocytoclastic, Cutaneous PMID:1676224
MESH:D018777 Multiple Chemical Sensitivity PMID:17075259
MESH:D020258 Neurotoxicity Syndromes PMID:16087284
MESH:D020567 Fetal Weight PMID:39866447
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:22317828; PMID:26862277; PMID:28243541; PMID:29981020
MESH:D058186 Acute Kidney Injury PMID:38408527; PMID:39866447

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.